Atrial flutter and atrial fibrillation have a complex relationship that has mechanistic, diagnostic, therapeutic and prognostic components. While thromboembolic risk management and pharmacological strategies share many similarities, there are important differences. Radiofrequency ablation should be considered to be an early, first-line alternative to pharmacological strategies for many patients with atrial flutter.